MS

Mididoddi Shiva Shankar

Active Director Director DIN 10629528
DIN 10629528 First appointment May 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Mididoddi Shiva Shankar

Data last updated:

Mididoddi Shiva Shankar is a Director at Avishzen Biotech Private Limited (since 2024).

DIN 10629528
Primary Designation Director
First Appointment 15 May 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Avishzen Biotech Private Limited U46497MH2024PTC425256
Director15 May 20242024Active

Board colleagues of Mididoddi Shiva Shankar

NameDINCompanyDesignation
Anil Gajula10629529Avishzen Biotech Private LimitedManaging Director
Gyara Vinay Kumar10629530Avishzen Biotech Private LimitedDirector

Directorship timeline

Open interactive timeline →
Avishzen Biotech Private Limited
Premium access

Shareholding and investment profile for Mididoddi Shiva Shankar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Mididoddi Shiva Shankar

Mididoddi Shiva Shankar currently holds 1 directorship: Avishzen Biotech Private Limited (Director, since 15 May 2024).

Mididoddi Shiva Shankar was first appointed on 15 May 2024 as Director at Avishzen Biotech Private Limited.

The current boards of Mididoddi Shiva Shankar's companies include Anil Gajula (Avishzen Biotech Private Limited), Gyara Vinay Kumar (Avishzen Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available